Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Cytosorbents (CTSO) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $62.8 million.

  • Cytosorbents' Shares Outstanding rose 1521.76% to $62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.8 million, marking a year-over-year increase of 1521.76%. This contributed to the annual value of $54.8 million for FY2024, which is 108.75% up from last year.
  • Latest data reveals that Cytosorbents reported Shares Outstanding of $62.8 million as of Q3 2025, which was up 1521.76% from $62.6 million recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Shares Outstanding registered a high of $62.8 million during Q3 2025, and its lowest value of $43.3 million during Q1 2021.
  • For the 5-year period, Cytosorbents' Shares Outstanding averaged around $49.5 million, with its median value being $44.2 million (2023).
  • Its Shares Outstanding has fluctuated over the past 5 years, first soared by 36.16% in 2022, then soared by 2430.25% in 2023.
  • Quarter analysis of 5 years shows Cytosorbents' Shares Outstanding stood at $43.5 million in 2021, then grew by 0.36% to $43.6 million in 2022, then increased by 24.3% to $54.2 million in 2023, then rose by 1.09% to $54.8 million in 2024, then increased by 14.53% to $62.8 million in 2025.
  • Its Shares Outstanding stands at $62.8 million for Q3 2025, versus $62.6 million for Q2 2025 and $62.5 million for Q1 2025.